Skip to main content
Fig. 4 | Genome Medicine

Fig. 4

From: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data

Fig. 4

Prognostic value of deconvolution-based immunoscore and T cell/ B cell score in solid cancers. Kaplan-Meier plots showing the survival of the Hi-Hi and Lo-Lo classes defined considering the deconvolution-based immunoscore computed for cervical endometrial cancer (CESC) patients (a) and the TB score computed for melanoma (SKCM) patients (b). The p value of the log-rank test, hazard ratio (HR) with 5% confidence intervals, and number of patients at risk at the respective time points are reported. c Results of the overall survival analysis across 19 TCGA solid cancers. Log2 hazard ratio and its 95% confidence interval are visualized for the deconvolution-based immunoscore and TB score as forest plots. Significant p values are indicated as ***p < 0.001, **0.001 ≤ p < 0.01, and *0.01 ≤ p < 0.05

Back to article page